| Dr George Bryant Hagan, MD | |
|
420 Nesbitt Lane, Madison, TN 37115 | |
| (615) 868-1098 | |
| Not Available |
| Full Name | Dr George Bryant Hagan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 420 Nesbitt Lane, Madison, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568695955 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | M.D.1732 (Tennessee) | Primary |
| 207R00000X | Internal Medicine | 17064 (Pennsylvania) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr George Bryant Hagan, MD 420 Nesbitt Lane, Madison, TN 37115 Ph: (615) 868-1098 | Dr George Bryant Hagan, MD 420 Nesbitt Lane, Madison, TN 37115 Ph: (615) 868-1098 |
News Archive
E2F5 is a member of the E2F transcription factor family, and plays a key role in cell growth and proliferation. Overexpression of E2F5 has been reported in various human cancers, but not in liver cancer, and its biological implication is largely unknown. It is not known whether E2F5 plays a tumor suppressor role or an oncogenic role.
Microsoft Corp. today announced "Microsoft Health Tech Today," a fast-paced online video series designed to showcase how software innovation is improving health around the world. The show, at the intersection of health and information technology, highlights the latest industry trends and features examples of proven solutions that are improving health and changing lives for clinicians, patients and consumers worldwide.
Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase.
Organizing this conference is a great honor, and highlights the Center's growing international profile, with the CNIC seeing off competition from an institute in Shanghai. The CNIC's candidature, led by Jos- Luis de la Pompa, was presented in 2011 by the Cardiovascular Development and Repair Department, and enjoyed institutional backing from important Spanish bodies including the Madrid regional government and the Spanish Society of Developmental Biology.
Immunologists at McMaster University have discovered a previously unknown mechanism which acts like a spider web, trapping and killing pathogens such as influenza or SARS-CoV-2, the virus responsible for COVID-19.
› Verified 9 days ago
Dr. Mene Sugage Zua, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1308 Briarville Rd, Madison, TN 37115 Phone: 615-868-3131 Fax: 615-515-0205 | |
Charles Winters Jr., M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1037 E Old Hickory Blvd, Madison, TN 37115 Phone: 615-860-0228 Fax: 615-865-2799 | |
Darrell G Arnett, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1205 S Graycroft Ave, Madison, TN 37115 Phone: 615-679-0132 Fax: 615-953-7903 | |
Marcus Min, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 607 W Due West Ave, Suite 122, Madison, TN 37115 Phone: 615-868-0600 Fax: 615-868-9544 | |
Dr. Kodihalli P Channabasappa, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 607 W Due West Ave, Suite 122, Madison, TN 37115 Phone: 615-865-6111 |